Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Cantor Fitzgerald
Accenture
Federal Trade Commission
US Army
Dow
Express Scripts
Fuji
UBS

Generated: April 19, 2018

DrugPatentWatch Database Preview

Iofetamine hydrochloride i-123 - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for iofetamine hydrochloride i-123 and what is the scope of iofetamine hydrochloride i-123 freedom to operate?

Iofetamine hydrochloride i-123
is the generic ingredient in one branded drug marketed by IMP and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for iofetamine hydrochloride i-123
Medical Subject Heading (MeSH) Categories for iofetamine hydrochloride i-123
Synonyms for iofetamine hydrochloride i-123
( inverted exclamation markA)-2-(N-Isopropyl)amino-4 inverted exclamation marka-iodophenylpropane
((sup 123)I)(+-)-N-Isopropyl-p-iodoamphetamine hydrochloride
(+-)-p-Iodo-(sup 123)I-N-isopropyl-alpha-methylphenethylamine hydrochloride
(+/-)-N-Isopropyl-p-Iodoamphetamine hydrochloride
1-(4-Iodophenyl)-N-isopropylpropan-2-amine hydrochloride
1-(4-iodophenyl)-N-propan-2-yl-2-propanamine hydrochloride
1-(4-iodophenyl)-N-propan-2-yl-propan-2-amine hydrochloride
1-(4-iodophenyl)-N-propan-2-ylpropan-2-amine
1-(4-iodophenyl)-N-propan-2-ylpropan-2-amine hydrochloride
116316-03-1
4-Iodo-N-isopropylamphetamine hydrochloride
82691-32-5
95896-48-3
A803593
AC1L1ITG
ACMC-1BU12
AK399909
AKOS015908631
Benzeneethanamine, 4-(iodo-(sup 123)I)-alpha-methyl-N-(1-methylethyl)-, hydrochloride, (+-)-
Benzeneethanamine, 4-iodo-alpha-methyl-N-(1-methylethyl)-, hydrochloride
Benzeneethanamine, 4-iodo-alpha-methyl-N-(1-methylethyl)-, hydrochloride (1:1)
Benzeneethanamine, 4-iodo-alpha-methyl-N-(1-methylethyl)-, hydrochloride, (+/-)-
CAS-82691-32-5
CCG-221998
CHEMBL1255865
CTK0H3361
D0YQ5L
DB-041308
DSSTox_CID_25774
DSSTox_GSID_45774
DSSTox_RID_81116
DTXSID3045774
EU-0100694
FT-0642831
I-120
I14-34654
Iofetamine HCl
Iofetamine hydrochloride
Iofetamine hydrochloride I 123 [USAN]
Iofetamine hydrochloride, analytical standard, for drug analysis
Iofetamine I123 hydrochloride
LP00694
LS-186659
MLS002153161
N-Isopropyl-p-iodoamphetamine hydrochloride
NCGC00094048-01
NCGC00261379-01
OR008335
OR140340
OR206349
SCHEMBL7755724
SMR001230655
Spectamine
SR-01000075216
SR-01000075216-1
Tox21_111239
Tox21_500694
VZ29246

US Patents and Regulatory Information for iofetamine hydrochloride i-123

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Imp SPECTAMINE iofetamine hydrochloride i-123 INJECTABLE;INJECTION 019432-001 Dec 24, 1987 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Express Scripts
US Army
UBS
AstraZeneca
Cipla
Merck
Federal Trade Commission
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.